Orris

massive blood transfusion for 10 marks Dnb final theory exam from standard textbook

Reading File
Finding Sources
Finding Sources
Searching PubMed

"massive transfusion"

Searching the Web

massive transfusion protocol guideline blood products 1:1:1 trauma 2025

Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources

Massive Blood Transfusion (MBT) / Massive Transfusion Protocol (MTP)

Definition

Massive transfusion is commonly defined as:
  • Replacement of one blood volume within 24 hours, or
  • Transfusion of >10 units of packed red blood cells (PRBCs) in 24 hours, or
  • Acute blood loss of >50% blood volume within 3 hours, or
  • Ongoing bleeding of about 150 mL/minute.
In active hemorrhage, dynamic definitions such as anticipated requirement of ≥4 units PRBC within 1 hour are more useful because waiting for 24-hour criteria delays treatment.

Indications

MTP should be activated in uncontrolled, life-threatening hemorrhage, for example:
  1. Major trauma, especially polytrauma with hemorrhagic shock
  2. Ruptured ectopic pregnancy or postpartum hemorrhage
  3. Ruptured abdominal aortic aneurysm
  4. Massive gastrointestinal bleed
  5. Major operative hemorrhage, for example liver transplantation or vascular surgery
  6. Bleeding with disseminated intravascular coagulation (DIC)
Important: Massive transfusion supports resuscitation but does not replace definitive control of bleeding by pressure, packing, surgery, angioembolization, or obstetric measures.
Tintinalli's Emergency Medicine, Massive Transfusion section.

Aims of massive transfusion

  1. Restore circulating volume and tissue perfusion.
  2. Maintain oxygen-carrying capacity.
  3. Prevent or treat trauma-induced and dilutional coagulopathy.
  4. Maintain platelets and fibrinogen.
  5. Correct hypothermia, acidosis, and hypocalcemia.
  6. Achieve early definitive hemostasis.

Management: Massive Transfusion Protocol

1. Immediate resuscitation and communication

  • Call for help and activate the institutional MTP.
  • Inform blood bank, operating room, surgeon/interventional radiologist, and anesthesia team.
  • Secure two large-bore IV cannulae, or rapid infusion catheter/central access.
  • Send blood before transfusion, if feasible:
    • Blood group and cross-match
    • CBC and platelet count
    • PT/INR, aPTT
    • Fibrinogen
    • ABG/VBG, lactate, ionized calcium, electrolytes
    • Thromboelastography (TEG) or rotational thromboelastometry (ROTEM), where available.
  • Monitor pulse, blood pressure, ECG, temperature, urine output, arterial blood gases, and serial coagulation studies.
  • Control hemorrhage simultaneously. Avoid excessive crystalloid infusion because it worsens dilutional coagulopathy and hypothermia.

2. Blood component therapy

If cross-matched blood is not immediately available:
  • Start group O uncross-matched PRBCs.
  • Use O Rh-negative PRBCs particularly in females of child-bearing potential when Rh group is unknown.
  • Switch to group-specific and then cross-matched blood as soon as possible.
Use balanced component resuscitation, commonly:
ComponentUsual empirical approach
PRBC1 part
Fresh frozen plasma (FFP)1 part
Platelets1 part
Thus, an initial ratio of PRBC:FFP:platelets = 1:1:1 is widely used, though local MTP packs may use 1:1:1 or 1:1:2. High plasma-to-RBC ratios and early platelets reduce dilutional coagulopathy. The precise optimal ratio remains uncertain.
Tintinalli's Emergency Medicine, Protocol section.

3. Fibrinogen replacement

Fibrinogen is often the first coagulation factor to reach critically low levels during massive bleeding.
  • Give cryoprecipitate or fibrinogen concentrate when fibrinogen is low.
  • A practical target in major bleeding is fibrinogen >1.5-2 g/L.
  • Higher targets may be needed in obstetric hemorrhage.
Cryoprecipitate is a concentrated source of fibrinogen and factor XIII.
Henry's Clinical Diagnosis and Management by Laboratory Methods, Massive Transfusion and Cryoprecipitate Transfusion sections.

4. Tranexamic acid

  • In traumatic hemorrhage, administer tranexamic acid early, ideally within 3 hours of injury, according to the clinical setting and protocol.
  • It is also used in postpartum hemorrhage.

5. Prevent the lethal triad

The lethal triad is:
  • Hypothermia
  • Acidosis
  • Coagulopathy
Management:
  • Warm the patient with forced-air warming.
  • Use blood/fluid warmers and rapid infusion devices.
  • Maintain adequate perfusion and oxygenation.
  • Avoid unnecessary crystalloids.
  • Correct hypocalcemia promptly.

6. Calcium replacement

Citrate in stored blood chelates ionized calcium. During rapid transfusion, especially with shock or hepatic dysfunction, citrate metabolism is impaired.
  • Monitor ionized calcium repeatedly.
  • Give IV calcium, such as calcium gluconate or calcium chloride as per local protocol, when ionized calcium is low or there is ECG/hemodynamic evidence of hypocalcemia.
Severe hypocalcemia may cause myocardial dysfunction, arrhythmia, hypotension, and worsening coagulopathy.
Barash, Cullen, and Stoelting's Clinical Anesthesia, Metabolic Derangements section.

Targets during resuscitation

Common practical targets are:
  • Normothermia: core temperature >35°C
  • Platelet count >50,000/µL in active bleeding
    • 100,000/µL for traumatic brain injury/neurosurgery
  • INR <1.5
  • Fibrinogen >1.5-2 g/L
  • Normal or near-normal ionized calcium
  • Correction of severe acidosis
  • Adequate urine output and falling lactate
Use TEG/ROTEM, when available, to tailor plasma, platelets, fibrinogen, and antifibrinolytic therapy.

Complications of massive transfusion

Metabolic and physiological

  1. Hypothermia due to rapid infusion of cold products
  2. Hypocalcemia due to citrate toxicity
  3. Hyperkalemia, especially with rapid transfusion of older stored blood
  4. Acid-base disturbances
    • Initially metabolic acidosis due to shock
    • Later metabolic alkalosis due to citrate metabolism
  5. Volume overload and pulmonary edema

Hematologic

  1. Dilutional thrombocytopenia
  2. Dilutional coagulopathy
  3. DIC in severe trauma, sepsis, obstetric catastrophe, or shock
  4. Hypofibrinogenemia

Transfusion-related

  1. Acute hemolytic transfusion reaction from incompatible blood
  2. Febrile non-hemolytic and allergic reactions
  3. Transfusion-associated circulatory overload (TACO)
  4. Transfusion-related acute lung injury (TRALI)
  5. Rarely, transfusion-transmitted infection
Major recognized complications include hypothermia, hypocalcemia, hyperkalemia, citrate toxicity, and dilutional coagulopathy.
Harrison's Principles of Internal Medicine, Nonimmunologic Transfusion Adverse Reactions section.

Conclusion

Massive transfusion is a coordinated, protocol-driven resuscitation for life-threatening hemorrhage. Early activation of MTP, balanced blood-component replacement, prompt fibrinogen and calcium correction, warming, frequent laboratory or viscoelastic monitoring, and rapid definitive control of bleeding are the essential principles.
Standard textbook references
  • Henry's Clinical Diagnosis and Management by Laboratory Methods, “Massive Transfusion.”
  • Tintinalli's Emergency Medicine, “Massive Transfusion” and “Protocol.”
  • Barash, Cullen, and Stoelting's Clinical Anesthesia, “Metabolic Derangements.”
  • Harrison's Principles of Internal Medicine, “Nonimmunologic Transfusion Adverse Reactions.”
Current protocols commonly use balanced 1:1:1 resuscitation, but component ratios should follow the hospital MTP and serial coagulation or TEG/ROTEM findings. A recent trauma protocol review similarly supports ratios ranging from 1:1:1 to 1:1:2 for plasma, platelets, and RBCs.
This is a shared conversation. Sign in to Orris to start your own chat.